5-hydroxymethylcytosine has been researched along with Pheochromocytoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bayley, JP; Bovée, JV; Breuning, MH; Briaire-de Bruijn, IH; Cornelisse, CJ; de Graaff, MA; Devilee, P; Frizzell, N; Hoekstra, AS; Hogendoorn, PC; Korpershoek, E; Kunst, HP; Ras, C; Seifar, RM; Suijker, J; van Minderhout, I | 1 |
1 other study(ies) available for 5-hydroxymethylcytosine and Pheochromocytoma
Article | Year |
---|---|
Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors.
Topics: 5-Methylcytosine; Adrenal Gland Neoplasms; Cell Nucleus; Cytosine; Fumarate Hydratase; Gene Silencing; HEK293 Cells; Histone-Lysine N-Methyltransferase; Humans; Immunohistochemistry; Mixed Function Oxygenases; Paraganglioma; Pheochromocytoma; Proto-Oncogene Proteins; Smooth Muscle Tumor; Succinate Dehydrogenase | 2015 |